METODES ET PATIENTS Il s'agit d'une étude clinique, prospective, monocentrique, non-randomisée, effectuée sur 105 patients atteints d'un glaucome à angle ouve1i médicalement non-contrôlé. Ces patients ont tous bénéficiés d'une SPIC, effectuée selon le geste chirurgicale standard (technique décrite dans l'article). Dans le cadre de cette étude, nous avons effectué un bilan ophtalmologique complet avant l'acte chirurgical puis un suivi postopératoire à 1et7 jours; l,2,3,6,9,12 mois et ensuite tous les 6 mois durant les dix années suivantes. 
Introduction
Deep sclerectomy with collagen implant (DSCI) is a non-penetrating filtration procedure used for the surgical treatment ofmedically uncontrolled open-angle glaucoma. It was first described by Fyodorov et al in 1989 . 1 It was conceived in an attempt to lower the incidence of early postoperative complications of conventional trabeculectomy (such as hypotony, hyphema, flat anterior chamber, choroidal detachment, choroidal effusion or hemorrhage, surgery-induced cataract and endophthalmitis) 2 -8 , without compromising on the success rate ofintraocular pressure (IOP) reduction.
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4 Medium term studies of this surgi cal procedure have already been reported in our previous reports. 12 -14 ' 25 In this study we present the long-tenn results (10 years) of DSCI. The IOP control, the rate of complications and the reduction of glaucoma treatment for the initial
Patients and Methods

Case selection
This clinical, prospective, monocentric, non-randomized, unmasked study was angle-closure, neovascular, congenital or juvenile glaucomas, lmown allergy to porcine collagen, previous argon laser trabeculectomy or eye surgery within 6 months prior to enrollment in the study, unwillingness to participate in the study, and pregnant or breast feeding women. Patients with operative perforation of the trabeculo-Descemet's membrane were purposely removed from this study.
The study was approved by the Ethics Committee of the University of Lausanne.
Every patient gave written informed consent before surgery. None of the authors have any financial interest in the study.
Preoperative examination
The data were obtained from the medical records of the patients. Every patient underwent complete ophthalmic examination that included best corrected visual acuity (BCVA) measured at 6 meters on Snellen's chart, biomicrosopy, Goldmann applanation tonometer IOP measurements, anterior chamber angle assessment using a 4 mÜTors contact lens, and fundus examination. The visual fields were tested using the Octopus 123 program G 1 (Interzeag AG, Schlieren, Switzerland).
Postoperative follow-up 6 Postoperative evaluation which included all preoperative examinations except for the visual fields were perfonned at 1 and 7 days; 1, 2, 3, 6, 9, 12 months and thcn every 6 months thereafter to complete a 10 years follow-up. The visual field examination was repeated every year. Complications are defined on table 3. Mains outcomes were the IOP, the BCVA, the number of medications, and the nature and rates of complication.
Surgical technique
All surgeries were performed under retrobulbar anesthesia. The technique has been described in details elsewhere. Postoperatively patients were treated with topical 6000 U/ml polymyxin, 0.35 % neomycin and 0.1 % dexamethasone tid for 4 weeks and with topical fluorometholone 1 mg/ml tid for 3 months thereafter.
Glaucoma collagen implant
The collagen implant is a cylindrical device (length: 2.5 mm; diameter: 1 mm) made from lyophilized porcine scleral collagen 12 (Aquaflow ® Staar Surgical AG, Nidau, Switzerland). This bio-compatible material is not known to induce systemic immunologie reactions. 15 Acting as a space maintainer after hydration the implant is progressively degraded roughly 6 to 9 months after surgery.
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Additional procedures
The additional procedures are reported on table 2 and were indicated based on the clinical aspect of the filtering bleb. Laser goniopuncture (Microruptor II; Lasag AG, Thun, Switzerland) in Q-switch mode (5 to 8 mJ) creates microscopie holes in the trabeculoDescemet's membrane allowing a direct passage of aqueous humor from the anterior chamber to the intra-scleral space. This procedure transforms a non-penetrating filtration procedure into a penetrating one.
'
19 After laser treatment, topical prednisolon acetate 1 % was administered tid for three days. Glaucoma medications was reintroduced when IOP > 18 mmHg.
Success rate
Surgety was considered as a complete success when IOP was :S 21 mmHg without glaucoma medication at last follow-up, as a qualified success when IOP was :S 21 mmHg including medication. lt was defined as a failure when IOP was < 6 mmHg or> 21 mmHg despite glaucoma medication, the eye required further glaucoma drainage surgery, developed phtisis bulbi, or lost light perception.
Statistical analysis
Results were analyzed using the Student's t test for comparison ofmeans, chi-square analysis for 2 x 2 tables, and Kaplan-Meier survival curves for long term success rate analysis. P was considered significant when <0.05.
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Results
One hundred and five eyes from 105 patients were enrolled in the study. Preoperatively mean defect and corrected lost variance were 13. There was only one significant complication during surge1y that consisted in a malignant glaucoma due to ciliary bloc. This complication was treated with cycloplegia medication, the IOP at the end of the follow-up period was 11 mmHg. Table 3 complications. This surgery requires a good surgical skill and the long-term results might differ depending on the surgeon's talent. The main difficulty lies in performing the dissection of the deep sclera and avoiding perforation of the thin trabeculo-Descemet' s membrane. In this series, perforation of the membrane occurred in 3 patients that were not included in the study. In cases of perforation into the anterior chamber, DSCI was converted into trabeculectomy. Sanchez et al. 24 reported that in this particular condition the success rate and complications were similar to that of trabeculectomy. 14 This paper presents the first study with a 10 year follow-up after DSCI. Our results indicate that DSCI remains a long-term successful procedure in stabilizing the IOP with low postoperative complication rates and a rather stable visual acuity. These outcomes confirm, on a long-term perspective, the results from previous papers in respects to efficacy and rate of complications compared to trabeculectomy.
10 -13 • 28 -31 In this context the reduced complication rates would present some benefice in preventing further sight degradation in eyes with significant glaucoma damages, and in reducing the duration, costs and extension of the postoperative managements. The DSCI shall be considered, in that respect, as a safer technique compared to trabeculectomy, and we shall advocate this surgery when a filtering procedure is indicated in eyes at high risks for sight threatening complications.
In addition the visual field also remained stable for the majority (63%) of patients.
When comparing the results at 96 months in Shaarawy study 25 , reporting a 57% complete success rate, with our 4 7% success at 10 years, we have to take into account some elements.
Seven patients had a failure at a mean of 109 months after surgery. Seven other patients <lied and 2 other were lost of follow up before the 10 years outcome. In a study on 436 patients with a mean age of7 l. l years, Sharma found that 29 .8% of the patients with glaucoma <lied within 10 years of diagnosis. 32 This figure compares with the 27.6% of mortality reported in this study. One of the problems mentioned by Sharma about published studies on the longtenn outcome of chronic glaucoma is that they are undertaken on patients who are recruited from the practices of glaucoma subspecialists whose patient profile tends to be skewed in the direction of difficult cases and include those with advance disease. The Kaplan-Meier curve that is generally used to demonstrate progression over time should therefore be interpreted in such cases with caution. 32 Altogether these long term events might explain the decrease in Schlemm's canal is exposed.
Legends for figures
B) Descemet's membrane exposure is performed with a mby knife.
C) The deep sclera is carefully extended further into the comeal stroma to expose at least 1-2 mm ofDescemet's membrane.
D) The deep sclera is excised using a diamond blade.
E) A toothed forceps is peeling off the inner wall of the Schlemm's canal.
F) The collagen implant is placed radially (in the center of the deep sclerectomy dissection) and secured with a single 10.0 nylon suture to the thin remaining scleral layer. 
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